Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

December 11, 2025 CD as API / Pharma applications

Biomimetic cyclodextrin enzyme models for modulation of P. aeruginosa quorum sensing and host immune response

Quorum sensing (QS) is the cell-to-cell communication on cell density, which is based on signal molecules,  N-acyl-homoserine lactones (AHLs) for

Continue reading

December 8, 2025 Drug delivery / Pharma applications

Fungal quorum sensing molecules as potential drugs in the treatment of chronic wounds and their delivery

Interestingly fungal quorum sensing signal molecules (QSMs) were found effective against bacterial biofilms hindering the healing of chronic non-healing wounds

Continue reading

December 4, 2025 CD derivatives / Drug delivery / Pharma applications

Novel delivery systems for Resveratrol

A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of

Continue reading

european commission flags on poles
December 2, 2025 CD derivatives / Pharma applications

First EMA regulation on the residues of betadex sulfobutylether sodium in foodstuffs of animal

Regulation (European Commission) No. 470/2009 lays down Community procedures for the establishment of residue limits of pharmaceutical active substances, excipients

Continue reading

December 1, 2025 CD as API / CD derivatives / Drug delivery / Pharma applications

From an Idea to a Journey: My Path Toward Treating Gout and Hyperuricemia With Cyclodextrins

When I look back at the last few years, it’s hard not to feel moved by what this project has

Continue reading

November 28, 2025 Drug delivery / Pharma applications

Beta-cyclodextrin/salicylic acid complex in pads for wart treatment

A novel product labeled as “SottSunFeli Maximum strength wart remover patches” containing beta-cyclodextrin and 30% salicylic acid as active ingredient

Continue reading

November 25, 2025 Drug delivery / Pharma applications

Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment

In a recent study, Professors Bodor and Buchwald review the use of cyclodextrin-enabled formulations to develop oral tablets of cladribine

Continue reading

a rat is standing on top of a plastic container
November 24, 2025 CD as API / CD derivatives / Pharma applications

A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each

Continue reading

November 20, 2025 Drug delivery / Pharma applications

Carvone derived cannabidiol enantiomers as novel anticonvulsants

Developmental epilepsy syndromes are characterized by recurrent seizures and developmental delays. Current anticonvulsants target γ-aminobutyric acid type A receptor signaling

Continue reading

November 19, 2025 CD as API / Pharma applications

Amitriptyline in reducing bronchoconstriction effects compared to methyl BCD

Bronchial asthma is a chronic inflammatory disease with rising prevalence worldwide. Apart from the immunological role of the tricyclic antidepressant

Continue reading

Posts pagination

«Previous Posts 1 … 8 9 10 11 12 … 129 Next Posts»

Recent Posts

  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (417)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (798)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (225)
  • Gene delivery (22)
  • Household products (1)
  • Household products (5)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (109)
  • Pharma applications (1,191)
  • Supramolecular systems (42)
  • Uncategorized (154)

Top Posts

  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Meow! In Japan cyclodextrins are taking cat products to the next level! 😺
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Lanosterol eye drops for cataract treatment
  • Special issue: Recent Trends in Carbohydrate-Based Therapeutics
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • International Conference on Nanomedicine and Drug Delivery Systems
  • Eva Pharma, DRL, Biocon and Zydus Cadila added to Voluntary Licensing Agreements for Remdesivir

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...